Evaluation of the intervention SCIN (Scleroderma Interdisciplinary).
Completed
- Conditions
- Scleroderma, Depression.
- Registration Number
- NL-OMON23309
- Lead Sponsor
- Reumacentrum Sint Maartenskliniek Nijmegen
- Brief Summary
Kwakkenbos L, Willems LM, van den Hoogen FHJ, van Lankveld WGJM, Beenackers H, van Helmond TF, Becker ES, van den Ende CHM. Cognitive-behavioural therapy targeting fear of progression in an interdisciplinary care program: a case study in systemic sclerosis. J Clin Psychol Med Settings. In press.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
1. Scleroderma, diagnosed by a rheumatologist following the ACR criteria;
2. High distress at two consecutive assessments (6 months between assessments): Cut-off: CES-D >= 16;
Exclusion Criteria
1. Life expectancy less than 1 year;
2. Acute serious complications;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is depression. This is measured using a combined score (mean) of two VAS questionnaires measuring depression. These measures will be completed twice a week before, during and after the intervention to assess whether this variable change over time.
- Secondary Outcome Measures
Name Time Method Data will be collected in two different manners:<br /><br>1. 8 Visual Analogue Scales;<br /><br>2. A set of questionnaires.<br /><br>The secondary outcome measures are visual analogue scales of Appearance Self Esteem (ASE), Fear of Progression (FoP), pain and fatigue.<br /><br>The set of questionnaires consists of 9 questionnaires on coping, physical functioning, depression, anxiety, ASE and FoP.